Ling Yang
41Patents
5h-index
148Co-inventors
68Inventor score
Filing activity: Jan 4, 2006 → Sep 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9962388B2 | Pyrrolopyrimidine compounds used as TLR7 agonist | Chemistry; Metallurgy | 9 | Active |
| US9968597B2 | Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same | Human Necessities | 8 | Active |
| US8661281B2 | USB HUB and power management method thereof | Emerging Cross-Sectional Technologies | 8 | Active |
| US7388060B2 | Catalyst component for olefin (co)polymerization, preparation thereof, a catalyst comprising the same and use thereof | Chemistry; Metallurgy | 7 | Active |
| US10183017B2 | Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of same | Human Necessities | 5 | Active |
| US10307412B2 | Quinoline derivative against non-small cell lung cancer | Human Necessities | 4 | Active |
| US10555949B2 | Pyrrolopyrimidine compounds used as TLR7 agonist | Chemistry; Metallurgy | 1 | Active |
| US10561657B2 | Pyrrolopyrimidine compound | Chemistry; Metallurgy | 1 | Active |
| US10035792B2 | Resorcinol derivative as HSP90 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US9238643B2 | Amide compounds | Chemistry; Metallurgy | 0 | Active |
| US12030880B2 | Iminosulfanone compound as bromodomain protein inhibitor and pharmaceutical composition and medical use thereof | Human Necessities | 0 | Active |
| US12336996B2 | Drug combination containing TLR7 agonist | Chemistry; Metallurgy | 0 | Active |
| US10815132B2 | Apparatus and method for treating waste water containing ammonium salts | Chemistry; Metallurgy | 0 | Active |
| US10301477B2 | Superhydrophilic coating composition | Chemistry; Metallurgy | 0 | Active |
| US11554115B2 | Quinoline derivative for treatment of triple-negative breast cancer | Human Necessities | 0 | Active |
| US12128047B2 | TLR7 agonist and pharmaceutical combination thereof for treating lung cancer | Chemistry; Metallurgy | 0 | Active |
| US10329277B2 | N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(3-methyl-2-OXO-2,3-dihydro-1h-benzo[d]imidazol-1-yl)pyrimidin-2-yl)amino)phenyl)acrylamide hydrochloride as an inhibitor of epidermal growth factor receptor activity | Chemistry; Metallurgy | 0 | Active |
| US9340821B2 | Specific fluorescent probe based on albumin pseudo-esterase hydrolysis reaction and use thereof | Physics | 0 | Active |
| US12195468B2 | TLR7 agonist for treating colorectal cancer and pharmaceutical combination thereof | Human Necessities | 0 | Active |
| US10561647B2 | Use of quinoline derivatives for treating oesophageal cancer and treatment method, pharmaceutical composition and kit thereof | Human Necessities | 0 | Active |
| US10947245B2 | Crystal form A of 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine for inhibiting toll-like receptor activity | Chemistry; Metallurgy | 0 | Active |
| US12180387B2 | Coating composition | Chemistry; Metallurgy | 0 | Active |
| US10155775B2 | Substituted amino six-membered saturated heteroalicycles as long-acting DPP-IV inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10780091B2 | TLR7 agonist maleate salt, crystalline forms C, D and E thereof, preparation methods and uses of maleate salt and crystalline forms | Chemistry; Metallurgy | 0 | Active |
| US10829492B2 | Amino pyrazolopyrimidine compound used as neurotrophic factor tyrosine kinase receptor inhibitor | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.